Company intelligence / Profile preview

Neuroservices-Alliance

Aix-en-Provence, Provence-Alpes-Côte d’Azur, Franceneuroservices-alliance.com ↗

Ownership: Private
Development stage: Commercial

Overview

Neuroservices‑Alliance does not have its own clinical results or proprietary pipeline. Instead, it offers comprehensive preclinical electrophysiology and behavioral testing services to pharmaceutical companies focused on central nervous system and pain drug discovery. Their expertise includes both in vitro and in vivo translational models using rodent and human tissues to accelerate lead selection/optimization, mechanism-of-action studies, target engagement validation, and biomarker identification from early research through IND-enabling studies.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeBiologicCell therapyDevicePeptidesAntibody
Industry: Drug Discovery Services

Partnerships

MaxWell BiosystemsAnatomic Incorporated

Beyond the preview

Go deeper on Neuroservices-Alliance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroservices-Alliance.

Explore the full profile